companydata.dkcompanydata.dk

Precision Antibiotics ApS: Financial statements 2025

CVR: 45363171

Source: annual report 2025, Danish Business Authority

28/01/2025 – 31/12/2025

Precision Antibiotics ApS (CVR 45363171) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -702,466 and a net result of DKK -981,035. Equity in the 2025 report amounted to DKK 38,629,439. The solvency ratio was 98.2%. The company had 2 employees in the financial year.

Gross Profit
DKK -702,466
Profit/Loss
DKK -981,035
Equity
DKK 38,629,439
Total Assets
DKK 39,327,842
Employees
2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Precision Antibiotics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Thomas Lars Andresen joins the board of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, Thomas Lars Andresen has joined the board of directors of Precision Antibiotics ApS.

Peter Juul Kristensen joins the board of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, Peter Juul Kristensen has joined the board of directors of Precision Antibiotics ApS.

Jonas Rosager Henriksen joins the board of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, Jonas Rosager Henriksen has joined the board of directors of Precision Antibiotics ApS.

Anders Elias Hansen joins the board of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, Anders Elias Hansen has joined the board of directors of Precision Antibiotics ApS.

Charlotte Vindfeldt joins the board of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, Charlotte Vindfeldt has joined the board of directors of Precision Antibiotics ApS.

TLA-HOLDING 2010 ApS registered as owner of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, TLA-HOLDING 2010 ApS is registered as an owner of Precision Antibiotics ApS with an ownership share of 15%.

Bastholm-Hansen Holding ApS registered as owner of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, Bastholm-Hansen Holding ApS is registered as an owner of Precision Antibiotics ApS with an ownership share of 15%.

JHSCI Holding ApS registered as owner of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, JHSCI Holding ApS is registered as an owner of Precision Antibiotics ApS with an ownership share of 15%.

MSF Family Invest A/S registered as owner of Precision Antibiotics ApSSep 26, 2025

As of September 26, 2025, MSF Family Invest A/S is registered as an owner of Precision Antibiotics ApS with an ownership share of 10%.

Jonas Rosager Henriksen joins Precision Antibiotics ApS as directorJan 28, 2025

As of January 28, 2025, Jonas Rosager Henriksen is registered as director of Precision Antibiotics ApS.

About Precision Antibiotics ApS

Precision Antibiotics ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jonas Rosager Henriksen. The board consists of Thomas Lars Andresen (chair), Anders Elias Hansen, Charlotte Vindfeldt and Jens Strathe. The company's owners include TLA-HOLDING 2010 ApS, Bastholm-Hansen Holding ApS and JHSCI Holding ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -702,466 and a net result of DKK -981,035. Equity in the 2025 report amounted to DKK 38,629,439.

Source: annual report 2025, Danish Business Authority